Tarlatamab Phase 3 Results: New SCLC Standard at ASCO 2025 ASCO 3 Mins Read Tarlatamab Phase 3 Results SCLC ASCO 2025 The tarlatamab phase 3 results for SCLC, shared at ASCO 2025, showed a…
